PNC Financial Services Group’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.05K Sell
86
-145
-63% -$5.66K ﹤0.01% 4679
2026
Q2
$4.65K Buy
+231
New +$4.32K ﹤0.01% 4394

Other funds holding TRAX

PNC Financial Services Group's TRAX Position: Q3 2026 in Review

PNC Financial Services Group reduced its First Tracks Biotherapeutics (TRAX) stake by 63% in Q3 2026, selling an estimated $5.66K and leaving 86 shares worth $3.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4679.

PNC Financial Services Group first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.65K in Q2 2026. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • PNC Financial Services Group held 86 shares of First Tracks Biotherapeutics worth $3.05K as of Q3 2026.
  • PNC Financial Services Group sold 145 First Tracks Biotherapeutics shares in Q3 2026, an estimated $5.66K.
  • First Tracks Biotherapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4679 holding.
  • PNC Financial Services Group first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • PNC Financial Services Group's First Tracks Biotherapeutics position peaked at $4.65K in Q2 2026.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.